ClinicalTrials.Veeva

Menu

The Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell Carcinoma of the Lung

B

Beatrice Aramini

Status

Completed

Conditions

Lung Cancer, Nonsmall Cell
CSC
Relapse/Recurrence

Treatments

Genetic: Exposure to lung cancer stem cells

Study type

Observational

Funder types

Other

Identifiers

NCT04634630
STEMCELL/1

Details and patient eligibility

About

The present study is a prospective cohort study. The aim is to assess the relationship between the presence of cancer stem-cells (CSC) and the risk of relapse in patients with early and locally advanced adenocarcinoma and squamous cell carcinoma of the lung

Enrollment

35 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with stage I, II or IIIA adenocarcinoma of squamous cell carcinoma of the lung
  • age between 18 and 85
  • R0 resection
  • availability of formalin-fixed, paraffin-embedded surgery specimen from the primary tumor
  • availability of fresh surgical specimen for cytofluorimetric analysis

Exclusion criteria

  • incomplete resection
  • unknown tumor, node or metastasis status
  • synchronous tumors
  • previous lung cancer

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems